Thivat E - Search Results

1

Optimal methionine-free diet duration for nitrourea treatment: a Phase I clinical trial.

Durando X, Thivat E, Farges MC, Cellarier E, D'Incan M, Demidem A, Vasson MP, Barthomeuf C, Chollet P. Durando X, et al. Among authors: thivat e. Nutr Cancer. 2008;60(1):23-30. doi: 10.1080/01635580701525877. Nutr Cancer. 2008. PMID: 18444132 Clinical Trial.

2

Second-line chemotherapy of disseminated malignant melanoma with cystemustine at 60 mg/m2: a phase II trial.

Thivat E, Durando X, D'Incan M, Cure H, Mouret-Reynier MA, Madelmont JC, Souteyrand P, Chollet P. Thivat E, et al. Anticancer Drugs. 2005 Oct;16(9):1003-7. doi: 10.1097/01.cad.0000176506.71304.ca. Anticancer Drugs. 2005. PMID: 16162977 Clinical Trial.

3

Long-term disease-free survival in advanced melanomas treated with nitrosoureas: mechanisms and new perspectives.

Durando X, Thivat E, D'Incan M, Sinsard A, Madelmont JC, Chollet P. Durando X, et al. Among authors: thivat e. BMC Cancer. 2005 Nov 15;5:147. doi: 10.1186/1471-2407-5-147. BMC Cancer. 2005. PMID: 16287507 Free PMC article.

4

Cystemustine in recurrent high grade glioma.

Durando X, Thivat E, Roché H, Bay JO, Lemaire JJ, Verrelle P, Chazal J, Curé H, Chollet P. Durando X, et al. Among authors: thivat e. J Neurooncol. 2006 Aug;79(1):33-7. doi: 10.1007/s11060-005-9096-7. Epub 2006 Mar 31. J Neurooncol. 2006. PMID: 16575534 Clinical Trial.

5

A methionine-free diet associated with nitrosourea treatment down-regulates methylguanine-DNA methyl transferase activity in patients with metastatic cancer.

Thivat E, Durando X, Demidem A, Farges MC, Rapp M, Cellarier E, Guenin S, D'Incan M, Vasson MP, Chollet P. Thivat E, et al. Anticancer Res. 2007 Jul-Aug;27(4C):2779-83. Anticancer Res. 2007. PMID: 17695447 Free article.

6

Temozolomide treatment of an adult with a relapsing medulloblastoma.

Durando X, Thivat E, Gilliot O, Irthum B, Verrelle P, Vincent C, Bay JO. Durando X, et al. Among authors: thivat e. Cancer Invest. 2007 Sep;25(6):470-5. doi: 10.1080/07357900701518164. Cancer Invest. 2007. PMID: 17882660

7

[Methionine dependency of cancer cells: a new therapeutic approach?].

Durando X, Thivat E, Gimbergues P, Cellarier E, Abrial C, Dib M, Tacca O, Chollet P. Durando X, et al. Among authors: thivat e. Bull Cancer. 2008 Jan;95(1):69-76. doi: 10.1684/bdc.2008.0550. Bull Cancer. 2008. PMID: 18230572 Free article. Review. French.

8

[Peritoneal mesothelioma: long survival with intraperitoneal chemotherapy, lanreotide and mucolytics].

Montmayeur G, Thivat E, Gimbergues P, Dib M, Leheurteur M, Curé H, Chollet P, Durando X. Montmayeur G, et al. Among authors: thivat e. Gastroenterol Clin Biol. 2008 Oct;32(10):874-5. doi: 10.1016/j.gcb.2007.11.010. Epub 2008 Mar 18. Gastroenterol Clin Biol. 2008. PMID: 18353584 Free article. French. No abstract available.

9

A new prognostic classification after primary chemotherapy for breast cancer: residual disease in breast and nodes (RDBN).

Chollet P, Abrial C, Durando X, Thivat E, Tacca O, Mouret-Reynier MA, Leheurteur M, Kwiatkowski F, Dauplat J, Penault-Llorca F. Chollet P, et al. Among authors: thivat e. Cancer J. 2008 Mar-Apr;14(2):128-32. doi: 10.1097/PPO.0b013e31816bdea2. Cancer J. 2008. PMID: 18391619

10

Measurement of residual disease after neoadjuvant chemotherapy.

Abrial C, Thivat E, Tacca O, Durando X, Mouret-Reynier MA, Gimbergues P, Penault-Llorca F, Chollet P. Abrial C, et al. Among authors: thivat e. J Clin Oncol. 2008 Jun 20;26(18):3094; author reply 3095. doi: 10.1200/JCO.2008.16.7817. J Clin Oncol. 2008. PMID: 18565900 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

55 results

Search Page